Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Director | June 04, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date June 04, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,656 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Other · Acquired 2,519 · Balance 34,656 F1: Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 4, 2026 17:23 UTC | Nutex Health Inc. NUTX · Entity 4803 | OtherCommon Stock | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0002018803-26-000003 · primary_doc.xml · nonDerivative · entry 1 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,656 F1 · price: Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 14:40 UTC | Nutex Health Inc. NUTX · Entity 4803 | PurchaseCommon Stock | 10 | $94.46 | $944.60 |
DisclosureSEC source: 0002018803-26-000002 · primary_doc.xml · nonDerivative · entry 1 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,137 Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 116 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002018803-26-000001 · primary_doc.xml · derivative · entry 3 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421 Underlying: Common Stock · 116 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 82 | $86.22 | $7,070.24 |
DisclosureSEC source: 0002018803-26-000001 · primary_doc.xml · nonDerivative · entry 2 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,127 F2 · shares: Of the 183 shares issued subsequent to vesting, 82 shares were sold to cover tax withholding obligations. Read SEC document |
| March 10, 2026 Filed Mar 11, 2026 21:52 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0002018803-26-000001 · primary_doc.xml · nonDerivative · entry 1 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 10, 2026 Filed Mar 18, 2026 14:40 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Unit · Derivative | 116 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002018803-26-000002 · primary_doc.xml · derivative · entry 2 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339 Underlying: Common Stock · 116 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026. F1 · balance_after: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026. Read SEC document |
| April 04, 2025 Filed Apr 14, 2025 20:15 UTC | Nutex Health Inc. NUTX · Entity 4803 | Tax withholdingCommon Stock | 34 | $72.10 | $2,451.30 |
DisclosureSEC source: 0001486189-25-000016 · primary_doc.xml · nonDerivative · entry 2 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,992 F2 · shares: Of the 143 shares issued subsequent to vesting, 34 shares were sold to cover tax withholding obligations. Read SEC document |
| March 10, 2025 Filed Apr 14, 2025 20:15 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 120 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000016 · primary_doc.xml · derivative · entry 3 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406 Underlying: Common Stock · 120 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 120 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. F3 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 120 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028. Read SEC document |
| March 01, 2025 Filed Apr 14, 2025 20:15 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionCommon Stock | 143 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-25-000016 · primary_doc.xml · nonDerivative · entry 1 Spears Kelvin · CIK 0002018803 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.